3880 related articles for article (PubMed ID: 33782940)
1. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
[TBL] [Abstract][Full Text] [Related]
2. Body weight management in overweight and obese breast cancer survivors.
Shaikh H; Bradhurst P; Ma LX; Tan SYC; Egger SJ; Vardy JL
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012110. PubMed ID: 33305350
[TBL] [Abstract][Full Text] [Related]
3. Dietary interventions for adults with chronic kidney disease.
Palmer SC; Maggo JK; Campbell KL; Craig JC; Johnson DW; Sutanto B; Ruospo M; Tong A; Strippoli GF
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011998. PubMed ID: 28434208
[TBL] [Abstract][Full Text] [Related]
4. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160
[TBL] [Abstract][Full Text] [Related]
5. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001892. PubMed ID: 30284724
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial interventions for preventing and treating depression in dialysis patients.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
[TBL] [Abstract][Full Text] [Related]
7. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
[TBL] [Abstract][Full Text] [Related]
8. Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis.
Mah JY; Choy SW; Roberts MA; Desai AM; Corken M; Gwini SM; McMahon LP
Cochrane Database Syst Rev; 2020 May; 5(5):CD012616. PubMed ID: 32390133
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
[TBL] [Abstract][Full Text] [Related]
12. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
[TBL] [Abstract][Full Text] [Related]
13. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Strippoli GF
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013165. PubMed ID: 32588430
[TBL] [Abstract][Full Text] [Related]
14. Interventions for improving sleep quality in people with chronic kidney disease.
Natale P; Ruospo M; Saglimbene VM; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2019 May; 5(5):CD012625. PubMed ID: 31129916
[TBL] [Abstract][Full Text] [Related]
15. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
[TBL] [Abstract][Full Text] [Related]
16. Home versus in-centre haemodialysis for people with kidney failure.
Cheetham MS; Ethier I; Krishnasamy R; Cho Y; Palmer SC; Johnson DW; Craig JC; Stroumza P; Frantzen L; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD009535. PubMed ID: 38588450
[TBL] [Abstract][Full Text] [Related]
17. Protein restriction for diabetic kidney disease.
Jiang S; Fang J; Li W
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014906. PubMed ID: 36594428
[TBL] [Abstract][Full Text] [Related]
18. Parenteral versus oral iron therapy for adults and children with chronic kidney disease.
O'Lone EL; Hodson EM; Nistor I; Bolignano D; Webster AC; Craig JC
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD007857. PubMed ID: 30790278
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
Hara T; Hijikata Y; Matsubara Y; Watanabe N
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
[TBL] [Abstract][Full Text] [Related]
20. Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 years.
Colquitt JL; Loveman E; O'Malley C; Azevedo LB; Mead E; Al-Khudairy L; Ells LJ; Metzendorf MI; Rees K
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD012105. PubMed ID: 26961576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]